| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |